Sharpless Calls For A Nimble, Flexible, More Efficient US FDA
Executive Summary
In his first speech to an outside group, Sharpless strikes a collaborative tone, saying he expects to listen to the advice of the FDA bar, as well as his own experts.
You may also be interested in...
US FDA Succession Question Looms For Biden Administration As Hahn Departure Nears
As is tradition, political appointments offer resignations when a new administration takes office. The incoming president can ask them to stay but often they are let go. Commissioner Hahn is expected to be among the many Trump administration agency heads who will depart.
US FDA Faces Succession Questions As Hahn’s Departure Nears
Plan specifying the acting head of FDA until new commissioner is confirmed references senior positions that no longer exist.
Stephen Hahn For US FDA Commissioner: Will Academic Experience Suffice For Confirmation?
The MD Anderson Cancer Center administrator's lack of significant government administration experience may inspire questions during the confirmation process.